QRxPharma Articles

US FDA sets PDUFA date for QRxPharma's resubmitted MoxDuo NDA

15 March 2013

Regulatory briefs from Astellas, Janssen, Biogen and Elan, and QRxPharma

17 January 2013

FDA delays approval of QRxPharma's pain drug MoxDuo

29 June 2012

QRxPharma value assed as Actavis deal finalized

29 March 2012

Actavis in deal with QRxPharma for novel pain drug

21 December 2011

Showing 1-5 of 5 articles

Go to beginningPrevious
  • 1
NextGo to end